Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio) low adjuvant dose
CTP-VLP-002
Phase 2 mab active
Quick answer
Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio) low adjuvant dose for Poliomyelitis is a Phase 2 program (mab) at CanSino Biologics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CanSino Biologics
- Indication
- Poliomyelitis
- Phase
- Phase 2
- Modality
- mab
- Status
- active